Simeprevir (TMC435) with peginterferon/ribavirin for chronic hcv genotype-1 infection in treatment-nai;auve patients: Results from quest-1, a phase III trial

Authors
Category Primary study
JournalGastroenterology
Year 2013
This article has no abstract
Epistemonikos ID: b359f5967663ce11af69e78ce725e774b893685b
First added on: Feb 05, 2025